Quantitative determination of antiviral nucleoside analog in DNA.
A technique for the analysis of the amount of an antiviral nucleoside analog incorporated into DNA, utilizing enzymatic digestion of DNA, followed by high-performance liquid chromatography is described. The cells or tissue samples were treated with perchloric acid to inactivate the nucleases, then digested with pronase in the presence of EDTA. DNA was purified by CsCl centrifugation followed by Sephadex chromatography and treatment with deoxyribonuclease 1 and venom phosphodiesterase. The deoxyribonucleoside monophosphates and the monophosphate of the nucleoside analog liberated from DNA were separated and quantitated by HPLC analysis and measurement of radioactivity. This assay is more sensitive, specific, and precise than the determination of DNA density shift. It is also applicable for nucleoside analogs which do not change the density of DNA either because of their structure or their very small degree of incorporation.
D000818:Animals; D000998:Antiviral Agents / Q000032:analysis*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000032:analysis; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D002851:Chromatography, High Pressure Liquid; D003561:Cytarabine / Q000031:analogs & derivatives / Q000032:analysis; D004279:DNA, Viral / Q000032:analysis*; D006564:Herpesviridae / Q000187:drug effects; D006868:Hydrolysis; D009705:Nucleosides / Q000032:analysis*
D000998:Antiviral Agents; D004279:DNA, Viral; D009705:Nucleosides; D003561:Cytarabine; D001086:Arabinofuranosyluracil; C026023:fiacitabine; C043457:fialuridine